Many speakers with dysarthria have reduced intelligibility[,] and improving intelligibility is often a primary intervention objective. Consequently, measurement of intelligibility provides important information that is useful for clinical decision-making. The present study compared two different measures of intelligibility obtained in audio-only and audio-visual modalities for 4 different speakers with dysarthria (2 with mild-moderate dysarthria; 2 with severe dysarthria) secondary to cerebral palsy. A total of 80 college-aged listeners provided word-by-word transcriptions and made percent estimates of intelligibility which served as dependent variables. Group results showed that transcription measures were higher than percent estimates of intelligibility overall. There was also an interaction between speakers and measures of intelligibility, indicating that the difference between transcription scores and percent estimates varied among individual speakers. Results revealed a significant main effect for presentation modality, with the audio-visual modality having slightly higher scores than the audio-only modality; however, presentation modality did not interact with speakers or with measures of intelligibility. Results suggest that standard clinical measurement of intelligibility using orthographic transcription may be more consistent than the use of more subjective percent estimates.

Keywords:
Cerebral palsy, Speech intelligibility, Dysarthria
This content is only available via PDF.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.